You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Horizons Ventures led the round, joined by Airbus Ventures, bringing the MIT spinout's fundraising total to date to more than $21 million.
The North Carolina State University team is working on scaling the technology further and may form a company to develop it commercially.
Genomics England has slashed storage costs by migrating to a new file system, while NIH's All of Us research program is seeking savings from a cloud environment.
The offering of common stock will be the second for Twist this year and the third since the company made its initial public offering in October 2018.
A group of researchers devised a DNA-based storage system that uses DNA molecules to record data and produces materials with immutable memory.
French biopreservation firm Imagene will provide Twist with DNAshell technology and services to advance the storage of digital data in DNA.
Evercore analysts set a price target of $30.50 for the company and said they see opportunities in DNA synthesis, NGS tools, pharmaceuticals, and DNA data storage.
The R&D collaboration will examine a Western Digital theory that moving computational power closer to large genomic datasets can speed up analysis.
Aside from its core synthetic biology business, the company has expanded into NGS and is looking to move into drug discovery and DNA data storage.
Technology Review reports on startup Catalog Technologies' prototype to store data as DNA.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.